Balt usa has aligned the united states mandatory reporting process with balt extrusion.Under this improved reporting process, "similar devices" between balt extrusion and balt usa have been defined.All complaints received by balt extrusion and related to such similar devices which are marketed in the united states by balt usa shall be evaluated by balt usa according to mdr requirements.A retroactive analysis was performed on legacy complaint records to identify any prior occurrences deemed mdr reportable.This complaint has been deemed mdr reportable under this program and recorded in the balt usa complaint management system.Balt usa's reference number: (b)(4).Here is the summary of event and investigation as reported by balt extrusion: "at this stage of analysis: the microcatheter's rupture may be caused by an overpressure during glue injection.The overpressure may be a consequence of a catheter's occlusion and/or if the physician uses a syringe < 2.5 cc during injection.Indeed, as mentioned in the ifu and on the labelling (see above picture), a syringe 2.5cc mini should be used during injection.The procedure must be stopped and the catheter removed immediately, if any resistance occurs during the injection.The microcatheter's magic are 100% controlled during manufacturing with a 7 bar pressure test.The rate of complaints is between (b)(4).Main complaints are due to a device misuse.Since 2009, (b)(4) complaints subjected to vigilance (i.E.Declaration to competent authority).They are now closed except one which is still in progress ((b)(4) dated 2015, october 23th in (b)(6)).None highlighted an acknowledged defect of the medical devices at this date.No similar complaint reported on the batch 00215946.Device history record (dhr): the dhr review indicates that all microcatheters succeeded the 7 bar pressure test (step #22, control #29) except one which was rejected (i.E.194/195 = 99.5%).So, all marketed magic resisted at least a 7 bar pressure.".
|